Your browser doesn't support javascript.
loading
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.
Kushida, Clete A; Shapiro, Colin M; Roth, Thomas; Thorpy, Michael J; Corser, Bruce C; Ajayi, Akinyemi O; Rosenberg, Russell; Roy, Asim; Seiden, David; Dubow, Jordan; Dauvilliers, Yves.
Afiliação
  • Kushida CA; Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Redwood City, CA, USA.
  • Shapiro CM; University of Toronto, Toronto, ON, Canada.
  • Roth T; Sleep Disorders and Research Center, Henry Ford Health System, Detroit, MI, USA.
  • Thorpy MJ; Department of Neurology, Montefiore Medical Center, New York, NY, USA.
  • Corser BC; Sleep Management Institute, Cincinnati, OH, USA.
  • Ajayi AO; Florida Pediatric Research Institute, Winter Park, FL, USA.
  • Rosenberg R; Neurotrials Research, Inc., Atlanta, GA, USA.
  • Roy A; Ohio Sleep Medicine and Neuroscience Institute, Dublin, OH, USA.
  • Seiden D; Avadel Pharmaceuticals, Chesterfield, MO, USA.
  • Dubow J; Avadel Pharmaceuticals, Chesterfield, MO, USA.
  • Dauvilliers Y; National Reference Centre for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia, Sleep Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, Univ Montpellier, INM INSERM, Montpellier, France.
Sleep ; 45(6)2022 06 13.
Article em En | MEDLINE | ID: mdl-34358324

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxibato de Sódio / Cataplexia / Narcolepsia Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxibato de Sódio / Cataplexia / Narcolepsia Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article